Cargando…

Immununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases

BACKGROUND: Several findings suggest that the amyloid precursor protein (APP) and the amyloid cascade may play a role in motor neuron disease (MND). OBJECTIVE: Considering that dementia is one of the most frequent non-motor symptoms in amyotrophic lateral sclerosis (ALS) and that hippocampus is one...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gómez-Pinedo, Ulises, Villar-Quiles, Rocio N., Galán, Lucia, Matías-Guiu, Jordi A., Benito-Martin, Maria S., Guerrero-Sola, Antonio, Moreno-Ramos, Teresa, Matías-Guiu, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099138/ https://www.ncbi.nlm.nih.gov/pubmed/27877154 http://dx.doi.org/10.3389/fneur.2016.00195

Ejemplares similares

Notch Signalling in the Hippocampus of Patients With Motor Neuron Disease
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2019)

Amyotrophic lateral sclerosis modifies progenitor neural proliferation in adult classic neurogenic brain niches
por: Galán, Lucía, et al.
Publicado: (2017)

Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging
por: Matías-Guiu, Jordi A., et al.
Publicado: (2016)

Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2
por: Sanclemente-Alaman, Inmaculada, et al.
Publicado: (2020)

Editorial: The Use of Biomaterials With Stem and Precursor Cells in Diseases of the Central Nervous System; A Step to Clinical Trials
por: Ramos-Zúñiga, Rodrigo, et al.
Publicado: (2021)

Editorial: COVID-19 in CNS and PNS: Basic and Clinical Focus on the Mechanisms of Infection and New Tools for the Therapeutic Approach
por: Matias-Guiu, Jorge, et al.
Publicado: (2022)

Familial multiple sclerosis and association with other autoimmune diseases
por: Pytel, Vanesa, et al.
Publicado: (2017)

Vitamin D increases remyelination by promoting oligodendrocyte lineage differentiation
por: Gomez‐Pinedo, Ulises, et al.
Publicado: (2019)

Variants of genes encoding TNF receptors and ligands and proteins regulating TNF activation in familial multiple sclerosis
por: Torre‐Fuentes, Laura, et al.
Publicado: (2020)

Chitosan–Hydroxycinnamic Acids Conjugates: Emerging Biomaterials with Rising Applications in Biomedicine
por: Ojeda-Hernández, Doddy Denise, et al.
Publicado: (2022)

Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study
por: Matías-Guiu, Jordi A., et al.
Publicado: (2015)

Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
por: Pytel, Vanesa, et al.
Publicado: (2019)

Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis
por: Matías-Guiu, Jorge, et al.
Publicado: (2020)

Recurrent Amyloid Material in Grafts Used in Patients with Lattice Corneal Dystrophy 2 (Meretoja’s Syndrome)
por: Huerva, Valentín, et al.
Publicado: (2014)

In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2023)

Sera from Patients with NMOSD Reduce the Differentiation Capacity of Precursor Cells in the Central Nervous System
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2021)

Modelos experimentales de desmielinización-remielinización
por: Torre-Fuentes, L., et al.
Publicado: (2020)

Experimental models of demyelination and remyelination()
por: Torre-Fuentes, L., et al.
Publicado: (2020)

The Integration of Cell Therapy and Biomaterials as Treatment Strategies for Remyelination
por: López-Muguruza, Eneritz, et al.
Publicado: (2022)

Alexander Disease Mutations Produce Cells with Coexpression of Glial Fibrillary Acidic Protein and NG2 in Neurosphere Cultures and Inhibit Differentiation into Mature Oligodendrocytes
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2017)

Management of neurological care during the COVID-19 pandemic()
por: Matías-Guiu, J., et al.
Publicado: (2020)

La gestión de la asistencia neurológica en tiempos de la pandemia de Covid-19
por: Matías-Guiu, J., et al.
Publicado: (2020)

Predominance of visuoconstructive impairment after mild COVID-19?
por: Díez-Cirarda, María, et al.
Publicado: (2022)

Convivir con Alzheimer /
por: Matías-Guiu Guía, Jordi
Publicado: (2004)

Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis
por: Ojeda-Hernández, Doddy Denise, et al.
Publicado: (2022)

Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders
por: Villar-Gómez, Natalia, et al.
Publicado: (2022)

Commentary: Immunochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases
por: Johnson, Ian Paul, et al.
Publicado: (2017)

Should we expect neurological symptoms in the SARS-CoV-2 epidemic?()
por: Matías-Guiu, J., et al.
Publicado: (2020)

¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?
por: Matías-Guiu, J., et al.
Publicado: (2020)

Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation
por: Matias-Guiu, Jordi A., et al.
Publicado: (2017)

Structural MRI correlates of PASAT performance in multiple sclerosis
por: Matias-Guiu, Jordi A., et al.
Publicado: (2018)

Identification of Cortical and Subcortical Correlates of Cognitive Performance in Multiple Sclerosis Using Voxel-Based Morphometry
por: Matías-Guiu, Jordi A., et al.
Publicado: (2018)

Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab
por: Matías-Guiu, Jorge, et al.
Publicado: (2020)

Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System
por: Ojeda-Hernández, Doddy Denise, et al.
Publicado: (2020)

Primary progressive aphasia: in search of brief cognitive assessments
por: Matias-Guiu, Jordi A, et al.
Publicado: (2022)

Are there cognitive and neuroimaging signatures in long COVID?
por: Matias-Guiu, Jordi A, et al.
Publicado: (2023)

Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

The role of scientific journal editors during the COVID-19 pandemic()
por: Matias-Guiu, J.
Publicado: (2020)

Nuevos tiempos, nuevas prioridades
por: Matias-Guiu, Xavier
Publicado: (2020)

El papel del editor de una revista científica durante la pandemia del Covid-19
por: Matias-Guiu, J.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s65qemvqd7plap5oheaccdv3ne